SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-16-583801
Filing Date
2016-05-09
Accepted
2016-05-09 16:06:22
Documents
4
Period of Report
2016-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d191797d8k.htm 8-K 13522
2 EX-99.1 d191797dex991.htm EX-99.1 37376
3 GRAPHIC g191797001.jpg GRAPHIC 8174
4 GRAPHIC g191797002.jpg GRAPHIC 6658
  Complete submission text file 0001193125-16-583801.txt   72671
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 161631675
SIC: 2834 Pharmaceutical Preparations